BI
MRSN

BVF Inc’s Mersana Therapeutics MRSN Stock Holding History

BVF Inc’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-94,896
Closed -$13.8M – 62
2020
Q1 		$13.8M Buy
94,896
+47,674
+101% +$8.33M 1.29% 24
2019
Q4 		$6.76M Sell
47,222
-114,454
-71% -$8.37M 0.51% 37
2019
Q3 		$6.39M Buy
161,676
+61,760
+62% +$4.49M 0.67% 39
2019
Q2 		$10.1M Sell
99,916
-84
-0.1% -$9.89K 1.1% 29
2019
Q1 		$13.2M Buy
+100,000
New +$12.6M 1.47% 24

Other funds holding MRSN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return